Nearly one third of Health Advances’ business involves M&A due diligence and valuation analyses. Health Advances works with both financial and strategic buyers and sellers to assist in understanding the market opportunity for the products or services involved in the deal. We then apply our rigorous forecasting skills and financial modeling to provide an objective perspective on the value of those products/services.
Health Advances’ ability to understand the scientific, clinical and business issues of each product or service it evaluates is unique and highly valued by our clients. Each year, Health Advances is asked to assist in the due diligence of dozens of deals, including many of the largest deals consummated in the industry each year. We have been actively involved in over $6 billion of consummated deals in the last 3 years.
View our Valuation and Financial Analysis case examples.